共 50 条
- [23] Dual-targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn's disease JOURNAL OF DERMATOLOGY, 2020, 47 (06): : E216 - E217
- [26] Ustekinumab for Treatment of Refractory Pyoderma Gangrenosum in a Crohn's Disease Patient AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1032 - S1032
- [27] Five Crohn's Disease Patients Treated With Vedolizumab for Pyoderma Gangrenosum AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1793 - S1794
- [28] Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 34 (05): : 558 - 560
- [29] Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (10): : 603 - 606
- [30] Successful Treatment of Pyoderma Gangrenosum With Vedolizumab in a Crohn's Disease Patient AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1184 - S1184